Westlake Village BioPartners — 2023 Investments
3 investments dated 2023 · listed companies and verified rows first · show all
Akamis Bio develops oncolytic immunotherapies for colorectal cancer treatment, aiming to offer alternatives to surgery that preserve patient function and quality of life.
BiotechDigital HealthHealthtechMedical DevicesCambridge, MA, US
Howard Davis, PhD(Chief Executive Officer)
Co-investorsARCH Venture PartnersSR One Capital ManagementIP GroupLundbeckfonden Ventures
A patient-focused biotechnology company developing adeno-associated virus (AAV)-based gene therapies to treat genetically defined muscle and heart diseases.
BiotechSan Diego, US
Kevin Forrest, Ph.D.(Executive Officer, Director)
BoardClare Ozawa, Ph.D.(Director)Beth Seidenberg, M.D.(Director)
Co-investorsOUP (Osage University Partners)Kleiner PerkinsVersant Ventures
Meanwhile is a licensed Bitcoin-denominated life insurance company whose policies collect premiums and pay death benefits in BTC, with premiums that grow at a guaranteed rate in Bitcoin terms and the option to take Bitcoin loans against policy value.
Crypto & Web3FintechInsurTechHamilton, BM
Tia Beckmann(Chief Financial Officer)inMax Gasner(Founder)Zac Townsend(Founder)in
Co-investorsFramework VenturesFulgur VenturesGradient VenturesSam Altman6th Man VenturesHaun Ventures+9 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.








